Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000907654-15-000002
Filing Date
2015-06-25
Accepted
2015-06-25 16:23:23
Documents
1
Effectiveness Date
2015-06-25
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12450
  Complete submission text file 0000907654-15-000002.txt   13778
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-242529 | Film No.: 15952047
SIC: 2835 In Vitro & In Vivo Diagnostic Substances